Cell-mediated immune response to human papillomavirus infection

Affiliations

Review

M Scott et al. Clin Diagn Lab Immunol. 2001 Mar.

. 2001 Mar;8(2):209-20.

doi: 10.1128/CDLI.8.2.209-220.2001.

¹ Department of Pediatrics, School of Medicine, University of California San Francisco, San Francisco, California 94143, USA. mscott@itsa.ucsf.edu

No abstract available

References

1. Alexander M, Salgaller M L, Celis E, Sette A, Barnes W A, Rosenberg S A, Steller M A. Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope. Am J Obstet Gynecol. 1996;175:1586–1593. - PubMed
1. al-Saleh W, Giannini S L, Jacobs N, Moutschen M, Doyen J, Boniver J, Delvenne P. Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix. J Pathol. 1998;184:283–290. - PubMed
1. Alter B J, Grillot-Courvalin C, Bach M L, Zier K S, Sondel P M, Bach F H. Secondary cell-mediated lympholysis: importance of H-2 LD and SD factors. J Exp Med. 1976;143:1005–1014. - PMC - PubMed
1. Arany I, Goel A, Tyring S K. Interferon response depends on viral transcription in human papillomavirus-containing lesions. Anticancer Res. 1995;15:2865–2869. - PubMed
1. Arany I, Rady P, Tyring S K. Effect of interferon therapy on human papillomavirus copy number in patients with condyloma acuminatum. Am J Med Sci. 1995;310:14–18. - PubMed